Seroprevalence of autoantibodies against brain antigens in health and disease, Ann Neurol, vol.76, pp.82-94, 2014. ,
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types, Ann Clin Transl Neurol, vol.1, pp.822-854, 2014. ,
Disease-relevant autoantibodies in first episode schizophrenia, J Neurol, vol.258, pp.686-694, 2011. ,
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications, Psychopharmacology, vol.233, pp.1605-1626, 2016. ,
Imaging of autoimmune encephalitis-Relevance for clinical practice and hippocampal function, Neuroscience, vol.309, pp.68-83, 2015. ,
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis, J Neurol, vol.135, pp.1622-1660, 2012. ,
The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data, Lancet Psychiatry, vol.6, pp.235-281, 2019. ,
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol, vol.7, pp.1091-1099, 2008. ,
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on bloodbrain barrier integrity, Mol Psychiatry, vol.19, pp.1143-1152, 2014. ,
Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a casecontrol study, Lancet Psychiatry, vol.4, pp.42-50, 2017. ,
Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children, Biol Psychiatry, vol.77, pp.537-584, 2015. ,
Cognitive functioning in prodromal psychosis: a metaanalysis, Arch Gen Psychiatry, vol.69, pp.562-71, 2012. ,
Severity of thought disorder predicts psychosis in persons at clinical high-risk, Schizophrenia Res, vol.169, pp.169-77, 2015. ,
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study, Arch Gen Psychiatry, vol.68, pp.489-95, 2011. ,
Structural hippocampal damage following anti-Nmethyl-D-aspartate receptor encephalitis, Biol Psychiatry, vol.79, pp.727-761, 2016. ,
Cognitive deficits following anti-NMDA receptor encephalitis, J Neurol Neurosurg Psychiatry, vol.83, pp.195-203, 2012. ,
Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis, Ann Neurol, vol.74, pp.284-96, 2013. ,
Neuronal autoantibodies associated with cognitive impairment in melanoma patients, Ann Oncol: Off J Eur Soc Med Oncol/ESMO, vol.30, pp.823-832, 2019. ,
High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients, J Neurol, vol.264, pp.1968-77, 2017. ,
N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis, Clin Microbiol Infect, vol.22, pp.934-974, 2016. ,
Brain-relevant antibodies in first-episode psychosis: a matched case-control study, Psychol Med, vol.48, pp.1257-63, 2017. ,
Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients, Nat Commun, vol.8, p.1791, 2017. ,
Cell-and single molecule-based methods to detect anti-Nmethyl-D-aspartate receptor autoantibodies in patients with firstepisode psychosis from the OPTiMiSE project, Biol Psychiatry, vol.82, pp.766-72, 2017. ,
All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class, Mol Psychiatry, vol.22, pp.1776-84, 2016. ,
Human cerebrospinal fluid monoclonal N-methyl-Daspartate receptor autoantibodies are sufficient for encephalitis pathogenesis, Brain: J Neurol, vol.139, pp.2641-52, 2016. ,
N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications, Ann Neurol, vol.83, pp.553-61, 2018. ,
Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder, Mol Psychiatry, vol.19, pp.1054-1060, 2014. ,
The blood-brain barrier in psychosis, Lancet Psychiatry, vol.5, pp.79-92, 2017. ,
Serum S100B is related to illness duration and clinical symptoms in schizophrenia-A meta-regression analysis, Front Cell Neurosci, vol.10, p.46, 2016. ,
Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia, PLoS ONE, vol.9, p.106342, 2014. ,
Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives, Clin Biochem, vol.47, pp.876-88, 2014. ,
Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification, JAMA Psychiatry, vol.73, pp.113-133, 2016. ,
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk, Arch Gen Psychiatry, vol.69, pp.220-229, 2012. ,
Can neuroimaging be used to predict the onset of psychosis?, Lancet Psychiatry, vol.2, pp.1117-1139, 2015. ,
Child maltreatment and clinical outcome in individuals at ultra-high risk for psychosis in the EU-GEI high risk study, Schizophrenia Bull, vol.44, pp.584-92, 2018. ,
Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study, BMC Public Health, vol.11, p.861, 2011. ,
The psychosis screening questionnaire, Int J Methods Psychiatr Res, vol.5, pp.11-20, 1995. ,
Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states, Aust NZ J Psychiatry, vol.39, pp.964-71, 2005. ,
Symptom monitoring in the rehabilitation of schizophrenic patients, Schizophrenia Bull, vol.12, pp.578-602, 1986. ,
The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations, Br J Psychiatry Suppl, vol.7, pp.49-58, 1989. ,
A rating scale for mania: reliability, validity and sensitivity, Br J Psychiatry: J Ment Sci, vol.133, pp.429-464, 1978. ,
A new depression scale designed to be sensitive to change, Br J Psychiatry: J Ment Sci, vol.134, pp.382-391, 1979. ,
Rey auditory and verbal learning test: a handbook, Western Psychological Services, 1996. ,
Manual for the Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1981. ,
Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis, J Neuroimmunol, vol.231, pp.86-91, 2011. ,
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes, Brain: J Neurol, vol.133, pp.1655-67, 2010. ,
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia, Brain, vol.133, pp.2734-2782, 2010. ,
C-reactive protein is elevated in schizophrenia, Schizophrenia Res, vol.143, pp.198-202, 2013. ,
Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis, Am J Psychiatry, vol.173, pp.392-401, 2016. ,
Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia, J Psychiatry Neurosci, vol.35, pp.33-40, 2010. ,
The psychiatric phenotype of anti-NMDA receptor encephalitis, J Neuropsychiatry Clin Neurosci, vol.31, pp.70-79, 2019. ,
Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E), Psychopharmacology, vol.122, pp.263-270, 1995. ,
Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited, JAMA Psychiatry, vol.71, pp.838-847, 2014. ,
Frequency and characteristics of isolated psychiatric episodes in anti-Nmethyl-d-aspartate receptor encephalitis, JAMA Neurol, vol.70, pp.1133-1142, 2013. ,
Early and chronic gray matter volume changes in limbic encephalitis revealed by voxel-based morphometry, Epilepsia, vol.56, pp.754-61, 2015. ,
Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis, J Neurol Neurosurg Psychiatry, vol.86, pp.735-777, 2015. ,
Serial MRI of limbic encephalitis, Neuroradiology, vol.48, pp.380-386, 2006. ,
Improvement in anti-N-methyl-d-aspartate receptor antibody-mediated temporal lobe epilepsy with amygdala enlargement without immunotherapy, Epilepsy Behav Case Rep, vol.10, pp.96-104, 2018. ,
Synaptic and neuronal autoantibody-associated psychiatric syndromes (SNAps): Controversies and Hypotheses. Front Psychiatry, vol.8, p.13, 2017. ,
Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis, NPJ Schizophr, vol.1, p.14006, 2015. ,
Increased postural sway predicts negative symptom progression in youth at ultrahigh risk for psychosis, Schizophrenia Res, vol.162, pp.86-95, 2015. ,
Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?, Psychiatry Res, vol.210, pp.427-458, 2013. ,
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice, Brain: J Neurol, vol.138, pp.94-109, 2015. ,
Autoantibodies against the N-methyl-d-aspartate receptor subunit NR1: untangling apparent inconsistencies for clinical practice, Front Immunol, vol.8, p.181, 2017. ,
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultrahigh-risk individuals, Arch Gen Psychiatry, vol.63, pp.139-188, 2006. ,
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment, Neurology, vol.78, pp.1743-53, 2012. ,
Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury, Mol Psychiatry, 2020. ,
The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1 ,
, Ann Neurol, vol.79, pp.144-51, 2016.
Time for a change of practice: the realworld value of testing for neuronal autoantibodies in acute firstepisode psychosis, BJPsych Open, vol.4, pp.262-266, 2018. ,
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review, Neuroimage Clin, vol.6, pp.262-74, 2014. ,
Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention, Mol Psychiatry, vol.23, pp.1764-72, 2018. ,
Non-reduction in hippocampal volume is associated with higher risk of psychosis, Schizophrenia Res, vol.58, pp.145-58, 2002. ,
Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome, Schizophrenia Res, vol.142, pp.108-123, 2012. ,
Neuropsychological test performance to enhance identification of subjects at clinical high risk for psychosis and to be most promising for predictive algorithms for conversion to psychosis: a meta-analysis, J Clin Psychiatry, vol.78, pp.28-40, 2017. ,
Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up, PLoS ONE, vol.9, p.93994, 2014. ,
Pfropfschizophrenie' revisited. Schizophrenia in people with mild learning disability, Br J Psychiatry: J Ment Sci, vol.173, pp.145-53, 1998. ,
, 14 ? Birte Glenthøj 15 ? Neus Barrantes-Vidal 16 ? Jim van Os 17,18 ? Bart P. F. Rutten 18 ? Rodrigo A. Bressan 19 ? Mark van der Gaag 20 ? Robert Yolken 21 ? Matthew Hotopf 22 ? Lucia Valmaggia 23, vol.2, p.3